Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Faurholt-Jepsen

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Danish Medical Journal|July 2, 2013
The double burdenDaniel Faurholt-Jepsen
Current Diabetes Reports|May 9, 2014
Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic reviewMarit Eika Jørgensen, Daniel Faurholt-Jepsen
International Health|March 12, 2019
Prevention of opportunistic non-communicable diseasesMaria H Hegelund, Daniel Faurholt-Jepsen, Ib C Bygbjerg
Biofilm|June 20, 2022
Prevalence of biofilms in acute infections challenges a longstanding paradigmMette Kolpen, Peter Østrup Jensen, Daniel Faurholt-Jepsen, et al.
Scandinavian Journal of Infectious Diseases|August 20, 2014
Mycobacterium bovis meningitis in young Nigerian-born maleDaniel Faurholt-Jepsen, Troels Lillebaek, Ming-Yuan Nielsen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 1, 2017
Prevalence and characteristics of chronic kidney disease among Danish adults with cystic fibrosisKristina H Berg, Lene Ryom, Daniel Faurholt-Jepsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 5, 2025
Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the LiteratureAnne Sofie Rosenborg Peretz, Thomas Bryrup, Daniel Faurholt-Jepsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 30, 2022
Opportunistic non-communicable diseases in times of COVID-19Maria Hein Hegelund, Lasse Fjordside, Daniel Faurholt-Jepsen, et al.
Infectious Diseases (London, England)|February 27, 2015
Height as a prognostic marker for survival during antituberculous therapyDaniel Faurholt-Jepsen, Nyagosya Range, George Praygod, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 29, 2022
Endotracheal lactate reflects lower respiratory tract infections and inflammation in intubated patientsMette Kolpen, Christian Dalby Sørensen, Daniel Faurholt-Jepsen, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Danish Medical Journal|July 2, 2013
The double burdenDaniel Faurholt-Jepsen
Current Diabetes Reports|May 9, 2014
Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic reviewMarit Eika Jørgensen, Daniel Faurholt-Jepsen
International Health|March 12, 2019
Prevention of opportunistic non-communicable diseasesMaria H Hegelund, Daniel Faurholt-Jepsen, Ib C Bygbjerg
Biofilm|June 20, 2022
Prevalence of biofilms in acute infections challenges a longstanding paradigmMette Kolpen, Peter Østrup Jensen, Daniel Faurholt-Jepsen, et al.
Scandinavian Journal of Infectious Diseases|August 20, 2014
Mycobacterium bovis meningitis in young Nigerian-born maleDaniel Faurholt-Jepsen, Troels Lillebaek, Ming-Yuan Nielsen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 1, 2017
Prevalence and characteristics of chronic kidney disease among Danish adults with cystic fibrosisKristina H Berg, Lene Ryom, Daniel Faurholt-Jepsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 5, 2025
Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the LiteratureAnne Sofie Rosenborg Peretz, Thomas Bryrup, Daniel Faurholt-Jepsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 30, 2022
Opportunistic non-communicable diseases in times of COVID-19Maria Hein Hegelund, Lasse Fjordside, Daniel Faurholt-Jepsen, et al.
Infectious Diseases (London, England)|February 27, 2015
Height as a prognostic marker for survival during antituberculous therapyDaniel Faurholt-Jepsen, Nyagosya Range, George Praygod, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 29, 2022
Endotracheal lactate reflects lower respiratory tract infections and inflammation in intubated patientsMette Kolpen, Christian Dalby Sørensen, Daniel Faurholt-Jepsen, et al.
Pageof 14